Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
Qi Li, Siyu He, Yao Chen, et al.
European Journal of Medicinal Chemistry (2018) Vol. 158, pp. 463-477
Closed Access | Times Cited: 173
Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Samuele Maramai, Mohamed Benchekroun, Moustafa T. Gabr, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-27
Open Access | Times Cited: 89
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 11
Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy
Ya Zhang, Zelin Hu, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114524-114524
Closed Access | Times Cited: 28
Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective
Xi Feng, Liao Dong-dong, Dongyu Liu, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15115-15139
Closed Access | Times Cited: 45
Research progress and perspectives of dual-target inhibitors
Xiaojing Pang, Wenyan Xu, Jing Liang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117453-117453
Closed Access
Synthesis of Nafimidone Derivatives by Visible-Light-Induced α-C—H Functionalization of Carbonyl
Jiabin Shen, Chao Shen, Pengfei Zhang
Chinese Journal of Organic Chemistry (2025) Vol. 45, Iss. 2, pp. 677-677
Closed Access
Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases
Qi Li, Shuaishuai Xing, Ying Chen, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111862-111862
Closed Access | Times Cited: 37
New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
R.S. Malek, Raquel L. Arribas, Alejandra Palomino‐Antolín, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 24, pp. 11416-11422
Closed Access | Times Cited: 36
Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease
Rakesh Kumar, Vinod Kumar, Bhupinder Kumar, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 10, pp. 1757-1803
Closed Access | Times Cited: 28
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases
Hualiang Shen, Xinde Xu, Yalong Bai, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115258-115258
Closed Access | Times Cited: 10
Arylbenzofurans from the Root Bark of Morus alba as Triple Inhibitors of Cholinesterase, β-Site Amyloid Precursor Protein Cleaving Enzyme 1, and Glycogen Synthase Kinase-3β: Relevance to Alzheimer’s Disease
Pradeep Paudel, Su Hui Seong, Yajuan Zhou, et al.
ACS Omega (2019) Vol. 4, Iss. 4, pp. 6283-6294
Open Access | Times Cited: 29
Critical evaluation of current Alzheimer’s drug discovery (2018–19) & futuristic Alzheimer drug model approach
Atukuri Dorababu
Bioorganic Chemistry (2019) Vol. 93, pp. 103299-103299
Closed Access | Times Cited: 25
Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
Daniela D’Arcangelo, Francesca Scatozza, Claudia Giampietri, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 446-446
Open Access | Times Cited: 23
A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies
İrem Bozbey, Zeynep Özdemir, Harun Uslu, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 11, pp. 1042-1060
Closed Access | Times Cited: 23
Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations
You Zhou, Xin Lü, Hongyu Yang, et al.
Molecules (2019) Vol. 24, Iss. 23, pp. 4217-4217
Open Access | Times Cited: 22
Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma
Takeshi Iwasaki, Kenichi Kohashi, Yu Toda, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 147, Iss. 5, pp. 1451-1463
Closed Access | Times Cited: 18
Eco-friendly synthesis and antifungal evaluation of N-substituted benzimidazoles
Diana Vargas‐Oviedo, Estefanía Butassi, Susana Zacchino, et al.
Monatshefte für Chemie - Chemical Monthly (2020) Vol. 151, Iss. 4, pp. 575-588
Closed Access | Times Cited: 17
The Protective Effect of IDO1 Inhibition in Aβ-Treated Neurons and APP/PS1 Mice
Zhenzhen Duan, Lei Shi, Zhen Ning Tony He, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2023) Vol. 38
Open Access | Times Cited: 5
Visible-light-induced controllable α-chlorination of nafimidone derivatives through LMCT excitation of CuCl2
Jiabin Shen, Zhihao Wang, Chao Shen, et al.
Molecular Catalysis (2023) Vol. 537, pp. 112950-112950
Closed Access | Times Cited: 4
An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases
João Paulo Bizarro Lopes, Luana Aparecida Alves da Silva, Diogo S. Lüdtke
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 12, pp. 2001-2015
Open Access | Times Cited: 10
Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studies
You Zhou, Xin Lü, Chenxi Du, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 34, pp. 127756-127756
Closed Access | Times Cited: 10
Azole antifungal compounds could have dual cholinesterase inhibitory potential according to virtual screening, enzyme kinetics, and toxicity studies of an inhouse library
Burak Barut, Suat Sarı, Suna Sabuncuoğlu, et al.
Journal of Molecular Structure (2021) Vol. 1235, pp. 130268-130268
Closed Access | Times Cited: 9
Potential of nafimidone derivatives against co‐morbidities of epilepsy: In vitro, in vivo, and in silico investigations
Suat Sarı, Burak Barut, Monika Marcinkowska, et al.
Drug Development Research (2021) Vol. 83, Iss. 1, pp. 184-193
Closed Access | Times Cited: 8
Discovery of Tryptophan‐tetrahydroisoquinoline Derivatives as Multifunctional Agents for Treatment of Alzheimer's Disease
Xin Lü, Yijun Liu, Nan Qin, et al.
Chinese Journal of Chemistry (2022) Vol. 40, Iss. 15, pp. 1821-1830
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top